TrialVox sanguinis2015

Intravenous iron isomaltoside 1000 (Monofer®) reduces postoperative anaemia in preoperatively non-anaemic patients undergoing elective or subacute coronary artery bypass graft, valve replacement or a combination thereof: a randomized double-blind placebo-controlled clinical trial (the PROTECT trial).

P I Johansson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.